Literature DB >> 18059173

hADA2a and hADA3 are required for acetylation, transcriptional activity and proliferative effects of beta-catenin.

Min Yang1, Marian L Waterman, Rainer K Brachmann.   

Abstract

Beta-catenin is the key transcriptional activator of the Wnt pathway important for development and tissue homeostasis of multicellular organisms. Its deregulation contributes to many human cancers. The beta-catenin transcriptional activator complex continues to be defined, but already contains several proteins with chromatin remodeling activity. Here we show that two members of histone acetyltransferase complexes without enzymatic activity, hADA2a and hADA3, are required for full activity of beta-catenin. hADA2a and hADA3 physically interact with beta-catenin, and the interaction is mediated through Armadillo repeats 6 through 12 and the C-terminal transactivation domain of beta-catenin. Both hADA2a and hADA3 reside with beta-catenin at the enhancer for the Wnt target gene c-Myc. RNA interference-mediated reduction of hADA2a and hADA3 results in reduced beta-catenin acetylation, reduced activity in reporter gene assays and reduced activation of endogenous beta-catenin target genes. Overall, loss of hADA2a and hADA3 negatively impacts beta-catenin-mediated proliferation. Our studies identify hADA2a and hADA3 as crucial cofactors of beta-catenin that are likely involved in the assembly of transactivation-competent beta-catenin complexes at Wnt target genes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18059173     DOI: 10.4161/cbt.7.1.5197

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  9 in total

1.  Acetylation of Mammalian ADA3 Is Required for Its Functional Roles in Histone Acetylation and Cell Proliferation.

Authors:  Shakur Mohibi; Shashank Srivastava; Aditya Bele; Sameer Mirza; Hamid Band; Vimla Band
Journal:  Mol Cell Biol       Date:  2016-09-12       Impact factor: 4.272

2.  Mammalian alteration/deficiency in activation 3 (Ada3) is essential for embryonic development and cell cycle progression.

Authors:  Shakur Mohibi; Channabasavaiah Basavaraju Gurumurthy; Alo Nag; Jun Wang; Sameer Mirza; Yousaf Mian; Meghan Quinn; Bryan Katafiasz; James Eudy; Sanjit Pandey; Chittibabu Guda; Mayumi Naramura; Hamid Band; Vimla Band
Journal:  J Biol Chem       Date:  2012-06-26       Impact factor: 5.157

Review 3.  Functions of SAGA in development and disease.

Authors:  Li Wang; Sharon Y R Dent
Journal:  Epigenomics       Date:  2014-06       Impact factor: 4.778

4.  A functional genomics screen identifies PCAF and ADA3 as regulators of human granzyme B-mediated apoptosis and Bid cleavage.

Authors:  D Brasacchio; T Noori; C House; A J Brennan; K J Simpson; O Susanto; P I Bird; R W Johnstone; J A Trapani
Journal:  Cell Death Differ       Date:  2014-01-24       Impact factor: 15.828

5.  Wnt interaction and extracellular release of prominin-1/CD133 in human malignant melanoma cells.

Authors:  Germana Rappa; Javier Mercapide; Fabio Anzanello; Thuc T Le; Mary G Johlfs; Ronald R Fiscus; Michaela Wilsch-Bräuninger; Denis Corbeil; Aurelio Lorico
Journal:  Exp Cell Res       Date:  2013-01-12       Impact factor: 3.905

6.  Ribosome-inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase-1 selectively in premalignant and malignant prostate cancer cells.

Authors:  Su Dao Xiong; Kang Yu; Xin Hua Liu; Li Hui Yin; Alexander Kirschenbaum; Shen Yao; Goutham Narla; Analisa DiFeo; Jian Buo Wu; Yong Yuan; Shuk-Mei Ho; Ying Wai Lam; Alice C Levine
Journal:  Int J Cancer       Date:  2009-08-15       Impact factor: 7.396

7.  Groucho binds two conserved regions of LEF-1 for HDAC-dependent repression.

Authors:  Laura Arce; Kira T Pate; Marian L Waterman
Journal:  BMC Cancer       Date:  2009-05-21       Impact factor: 4.430

8.  Integrated analysis of recurrent properties of cancer genes to identify novel drivers.

Authors:  Matteo D'Antonio; Francesca D Ciccarelli
Journal:  Genome Biol       Date:  2013-05-29       Impact factor: 13.583

Review 9.  Tale of a multifaceted co-activator, hADA3: from embryogenesis to cancer and beyond.

Authors:  Vaibhav Chand; Deeptashree Nandi; Anita Garg Mangla; Puneet Sharma; Alo Nag
Journal:  Open Biol       Date:  2016-09       Impact factor: 6.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.